Related Experiment Video
Updated: Mar 24, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Critical Care Management of the Patient with Pulmonary Hypertension
J Deschamps1, E Cornell2, N Kumar3
1Division of Surgical Critical Care, Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Abstract:
Pulmonary hypertension, defined as an elevation of the mean pulmonary artery pressure above 20 mm Hg, is an increasingly common diagnosis in patients admitted to the intensive care unit either as a primary pathology or as the result of other medical conditions. Proper assessment to identify the contributing factors and identify key specific etiologies is essential to properly manage these patients and improve patient outcomes. A subset of patients with causes of pulmonary hypertension such as Group 1 pulmonary arterial hypertension or Group 4 chronic thromboembolic pulmonary hypertension require specific treatments that deviate from usual intensive unit care and are critical to patients' survival. These patients and patients with advanced pulmonary hypertension from other causes may benefit from specialized treatments targeting the right ventricle and pulmonary circulation complex, and warrant transfer to a center with pulmonary hypertension expertise. This review will discuss pulmonary hypertension epidemiology, physiology of the right ventricle and pulmonary circulation complex, stepwise diagnosis and classification of patients, management of cardiorespiratory support medications and devices, perioperative considerations, and special populations such as transplant candidates and pregnancy.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

